Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Exchange Rate Effect (2016 - 2020)

Historic Exchange Rate Effect for Ernexa Therapeutics (ERNA) over the last 11 years, with Q4 2020 value amounting to $1000.0.

  • Ernexa Therapeutics' Exchange Rate Effect fell 9333.33% to $1000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$67000.0, marking a year-over-year decrease of 25952.38%. This contributed to the annual value of $11000.0 for FY2020, which is 7380.95% down from last year.
  • Latest data reveals that Ernexa Therapeutics reported Exchange Rate Effect of $1000.0 as of Q4 2020, which was down 9333.33% from -$71000.0 recorded in Q1 2020.
  • Ernexa Therapeutics' Exchange Rate Effect's 5-year high stood at $53000.0 during Q1 2016, with a 5-year trough of -$71000.0 in Q1 2020.
  • Over the past 5 years, Ernexa Therapeutics' median Exchange Rate Effect value was $1000.0 (recorded in 2020), while the average stood at -$941.18.
  • As far as peak fluctuations go, Ernexa Therapeutics' Exchange Rate Effect skyrocketed by 45000.0% in 2017, and later plummeted by 57142.86% in 2018.
  • Over the past 5 years, Ernexa Therapeutics' Exchange Rate Effect (Quarter) stood at -$17000.0 in 2016, then skyrocketed by 58.82% to -$7000.0 in 2017, then plummeted by 571.43% to -$47000.0 in 2018, then skyrocketed by 131.91% to $15000.0 in 2019, then plummeted by 93.33% to $1000.0 in 2020.
  • Its Exchange Rate Effect stands at $1000.0 for Q4 2020, versus -$71000.0 for Q1 2020 and $15000.0 for Q4 2019.